How effective is Symbicort for Chronic Obstructive Pulmonary Disease? (a real world drug study)
Summary:
Overall ratings: 3.2/5 Long term ratings: 3.3/5
This is a phase IV clinical study of how effective Symbicort (budesonide; formoterol fumarate dihydrate) is for Chronic obstructive pulmonary disease and for what kind of people. The study is created by eHealthMe from 297 Symbicort users and is updated continuously.
What is Symbicort?
Symbicort has active ingredients of budesonide; formoterol fumarate dihydrate. It is often used in asthma. eHealthMe is studying from 114,792 Symbicort users. Check the latest studies of Symbicort.
What is Chronic obstructive pulmonary disease?
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe) is found to be associated with 1,809 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Chronic obstructive pulmonary disease.
297 people are studied for taking Symbicort in Chronic obstructive pulmonary disease
Overall effectiveness (number of people):
Long term (1+ years) effectiveness (number of people):
Symbicort effectiveness for Chronic obstructive pulmonary disease (number of people):
Overall:
- not at all: 10
- somewhat: 57
- moderate: 119
- high: 90
- very high: 21
Long Term:
- not at all: 2
- somewhat: 28
- moderate: 87
- high: 62
- very high: 13
Gender of people who take Symbicort for Chronic obstructive pulmonary disease *:
- female: 59.26 %
- male: 40.74 %
Age of people who take Symbicort for Chronic obstructive pulmonary disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.34 %
- 20-29: 1.6800000000000002 %
- 30-39: 1.6800000000000002 %
- 40-49: 7.07 %
- 50-59: 26.94 %
- 60+: 62.29 %
Who find Symbicort more effective for Chronic Obstructive Pulmonary Disease?
Gender of people who take Symbicort for Chronic obstructive pulmonary disease *:
- female: 63.06 %
- male: 36.94 %
Age of people who take Symbicort for Chronic obstructive pulmonary disease *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.9 %
- 30-39: 0.0 %
- 40-49: 10.81 %
- 50-59: 28.83 %
- 60+: 59.46 %
* Approximation only. Some reports may have incomplete information.
Do you take Symbicort?
- You can start a phase IV clinical trial to monitor Symbicort safety and effectiveness.How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Alternative drugs to, pros and cons of:
- Symbicort (114,792 reports)
Treatments, associated drugs and conditions:
- Chronic obstructive pulmonary disease (198,253 reports)
How the study uses the data?
The study is based on budesonide; formoterol fumarate dihydrate (the active ingredients of Symbicort) and Symbicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study neither.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Atripla and Hip Joint Replacement for Men aged 40-49 - 3 seconds ago
- Atripla and Total Hip Replacement for Men aged 40-49 - 4 seconds ago
- Atripla and Hip Hemiarthroplasty for Men aged 40-49 - 4 seconds ago
- Atripla and Hip Arthroplasty for Men aged 40-49 - 4 seconds ago
- Dulcolax and Milk Of Magnesia drug interactions for women aged 50-59 - 7 seconds ago
- Drug interactions of Nicoderm Cq and Risperdal - 9 seconds ago
- Could Oxaliplatin cause Swelling? - 19 seconds ago
- Drug interactions of Lenalidomide and Keflex - 22 seconds ago
- Glucophage Xr and Zetia drug interactions for women aged 60+ - 23 seconds ago
- Could Botox cause Stroke? - 24 seconds ago